Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.2 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |